1. Home
  2. OCGN vs ELVA Comparison

OCGN vs ELVA Comparison

Compare OCGN & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.80

Market Cap

570.5M

Sector

Health Care

ML Signal

HOLD

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$9.57

Market Cap

359.5M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCGN
ELVA
Founded
2013
1996
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
570.5M
359.5M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
OCGN
ELVA
Price
$1.80
$9.57
Analyst Decision
Strong Buy
Buy
Analyst Count
4
1
Target Price
$9.75
$14.00
AVG Volume (30 Days)
8.4M
274.3K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
31.58
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$34.68
Revenue Next Year
$1,718.38
$51.48
P/E Ratio
N/A
$78.51
Revenue Growth
N/A
N/A
52 Week Low
$0.64
$2.46
52 Week High
$2.73
$11.88

Technical Indicators

Market Signals
Indicator
OCGN
ELVA
Relative Strength Index (RSI) 46.44 66.87
Support Level $1.51 $7.10
Resistance Level $1.93 $11.67
Average True Range (ATR) 0.11 0.56
MACD -0.02 0.19
Stochastic Oscillator 26.74 99.80

Price Performance

Historical Comparison
OCGN
ELVA

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

Share on Social Networks: